OCEANS are home to a variety of lifeforms that are potential sources for novel drug discovery. Comparatively, marine organisms have a shorter history than the longstanding history of terrestrial organisms, for utilization in the field of medicine 1 . Sessile marine organisms such as sponges are known to rely mainly on toxic or noxious secondary metabolites for defence against predators and pathogens, and during allelopathic competition with neighbouring organisms for space or resources 2 . Consequently, marine invertebrates have become established as an outstanding producer of biological molecules with unprecedented structural features and important bioactivities 3 . However, many such compounds originally regarded as products of marine invertebrates have subsequently turned out to be biosynthesized by host associated microorganisms. A convincing example is the secondary metabolite jasplakinolide which initially was presumed to be produced by a Jaspis sp. (Phylum: Porifera), but turned out to be actually biosynthesized by a spongederived fungus 4 .
The limited number of recent studies on fungi derived from marine organisms has been productive and yielded many novel bioactive natural products. With the number of compounds reported increasing annually, there is great potential to isolate novel bioactive metabolites from these sparsely studied microorganisms 5 . Sponges have been shown to yield the greatest taxonomic diversity for marine-derived fungi and not surprisingly fungi isolated from marine sponges account for the discovery of the majority of novel fungal metabolite from the oceans 5, 6 . Marine molluscs, sponges and soft corals of Sri Lanka, an island surround by the Indian Ocean, have yielded numerous novel metabolites [7] [8] [9] [10] . However, fungi associated with Sri Lankan marine organisms, remains an untapped resource that awaits exploration. We report here the isolation of fungi from the internal tissues of a marine demosponge, the antimicrobial activities of the crude extracts of the fungi, and the bioassay guided isolation of active metabolites from the crude extract of Aspergillus flavipes (KR063133), along with structure elucidation and antimicrobial activities of the isolated compounds.
Materials and methods

Isolation of fungi from a demosponge
A marine sponge of the class Demospongiae was collected from the Indian Ocean, near Dehiwala, Sri Lanka, in January 2014 and brought to the laboratory cooled in ice. Fungal isolation from the internal tissues was carried out within 12 h of sponge collection. Sponge voucher specimen (PR-D4) was deposited at the Natural Products Laboratory, Department of Chemistry, University of Colombo. To isolate the fungi occupying the internal tissues, the sponge was washed well with sea water and a small section was cut and was surface sterilized with 70% ethanol for 1 min. Then, this was cut into small pieces under sterile conditions and was crushed using a small amount of sterilized distilled water. The extract obtained was spread on pre-prepared sterile media dishes of potato dextrose agar (PDA), starch yeast peptone agar (SYP), yeast peptone dextrose agar (YPD), malt agar (ME) and malt peptone dextrose agar (MEA), enriched with antibiotic (chloramphenicol 50 mg/l) under aseptic conditions, and incubated at room temperature for several days. The media were prepared using unpolluted sea water in order to provide a marine environment for the normal growth of fungi. The fungi appearing on the media were transferred on to new PDA medium dishes prepared using sea water and sequence subculturing was done until pure cultures were obtained.
Antimicrobial evaluations of the crude fungal extracts
Each isolated fungus was grown on five PDA dishes and after the incubation period, fungus plus the medium were cut, immersed in 200 ml of ethyl acetate (EtOAc) for 24 h, filtered and the filtrate was evaporated to dryness using a rotary evaporate (BUCHI-R-200). The resulting crude fungal extracts were tested in triplicate against three Gram positive bacteria, Staphylococcus aureus (ATCC 43300), methicillin resistant Staphylococcus aureus (MRSA, ATCC 33591), Bacillus cereus (UBC 344), two Gram negative bacteria, Pseudomonas aeruginosa (ATCC 27853) and Escherichia coli (UBC 8161) and a pathogenic fungus Candida albicans (ATCC 90028) at 200 g/disc using the standard agar disc diffusion assay 11 .
[+ve controls -Polymyxin B (30 g/disc) for B. subtilis, P. aeruginosa and E. coli, Rifamycin (10 g/disc) for S. aureus and MRSA and Amphotericin B (20 g/disc) for C. albicans. Methanol solutions were used to transfer the crude extracts on to the discs and discs were dried prior to testing; -ve control -methanol]. The mean diameter of the zones of inhibition was recorded after overnight incubation.
Identification of the isolated bioactive fungus
The bioactive fungus was identified using morphological features and molecular biological techniques. For molecular identification, the fungal genomic DNA was extracted using a published protocol while the PCR and DNA sequencing were done commercially 12 . The acquired gene sequence was analysed by BLAST to obtain the identity of the fungus. The DNA sequence was also submitted to the NCBI GenBank database and an accession number was obtained. The preserved fungal voucher specimens were stored at 4C at the Natural Products Laboratory, Department of Chemistry, University of Colombo, Sri Lanka.
Extraction and isolation of the bioactive secondary metabolites
The bioactive fungal strain (PR-D4-3) was grown on sterile PDA in 300 petri dishes (size, 100  20 mm) prepared using sea water, and incubated for 10 days at room temperature. Next, the fungus and culture medium were cut into small pieces and were extracted with EtOAc (3  1 l). The extracts were filtered and the combined extract was concentrated in vacuo and was tested for antimicrobial activity against the three Gram-positive bacteria, MRSA, S. aureus and Bacillus subtilis at 50 g/disc using the agar disc diffusion method to confirm the activity 11 . To isolate the bioactive components from the complex mixture of the EtOAc extract, a series of bioassay guided chromatographic techniques that included in sequence, size-exclusion chromatography on Sephadex LH-20, normal phase silica gel chromatography using gradient elution and final reversed phase high performance liquid chromatography (HPLC) purifications were performed. The details of the isolation protocol which resulted in the isolation of five pure compounds 1-5, are given in Figure 1 .
Structure elucidation of the isolated compounds
The structure elucidation of the isolated compounds 1-5 was accomplished by analysis of NMR and mass spectral data.
1 H, 13 C and 2D NMR spectral data sets for 1, 3 and 4 in DMSO-d 6 were obtained using a Bruker AV-600 spectrometer with a 5 mm CPTCI cryoprobe. Low resolution ESI-QIT-MS were recorded on a Bruker-Hewlett Packard 1100 Esquire-LC system mass spectrometer. The structures of the compounds 2 and 5 were obtained by comparison of 1 H and 13 C data (in DMSO-d 6 ) with previously reported data (2 in CDCl 3 and 5 in DMSO-d 6 ).
Antimicrobial activities of the isolated compounds
Compounds 1-5 were tested for antimicrobial activity against three Gram-positive bacteria, B. subtilis (UBC 344), S. aureus (ATCC 43300) and methicillin resistant S. aureus (MRSA, ATCC 33591), two Gram-negative bacteria, E. coli (UBC 8161), P. aeruginosa (ATCC 27853) and pathogenic fungus C. albicans (ATCC 90028). The broth micro-dilution method according to the National Committee for Clinical Laboratory Standards with replacement using Mueller Hinton broth as the medium was used to determine the minimum inhibitory concentrations (MICs) of the compounds 13 . The MIC end point was taken as the lowest concentration with more than 90% growth inhibition. ADTX 880 (Beckman Coulter Inc.) plate reader was used to determine the optical density of the microbial growth at 600 nm. The positive 
Results
Isolation, antimicrobial activity of the crude extracts and identification of the fungi
Three fungi were isolated from the surface sterilized tissues of the demosponge using media rich in malt. Fungi PR-D4-1 and PR-D4-3 were isolated from ME medium, whereas PR-D4-2 fungus was isolated from MEA medium. The crude EtOAc extract of the fungus PR-D4-3, showed antibacterial activity against the Gram positive bacteria B. subtilis, MRSA and S. aureus with zones of inhibition 15, 17 and 17 mm, respectively for the initial screening at 200 g per disc. The crude extract of PR-D4-3 showed no activity for Gram-negative E. coli or P. aeruginosa and the pathogenic fungus C. albicans. The extracts of the other two isolated fungi, PR-D4-1 and PR-D4-2, were inactive for all the tested microorganisms.
Fungal mycelium of PR-D4-3 fungus was white and secreted a yellow pigment to the medium within 6-7 days of culture. According to the DNA sequence and blast results, this fungus showed 100% identity to the previously isolated Aspergillus flavipes species (e.g. accession number AY373849). Therefore, on the basis of its internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene and internal transcribed spacer 2, complete sequence; and 28S ribosomal RNA gene, partial sequence, the PR-D4-3 fungus isolated in the current study was assigned as A. flavipes (NCBI GenBank accession number: KR063133). 4 for compounds 1, 2 and 3 respectively, which were in agreement with the molecular weights of 401, 399, 401 daltons as determined by the LRESIMS. Detailed analysis of the spectral data revealed that the structures of the isolated compounds 1-3 matched those of the known cytochalasans, aspochalasin D, aspochalasin B and M respectively [14] [15] [16] . The structure for each compound was confirmed by comparison of the 13 C and 1 H spectral data with that previously reported in the literature [14] [15] [16] . The spectra obtained during the current study are given in the supporting documents while a comparison of 13 C values obtained for 1-3 in the present study and published data are given in Table 1 (5) 18 . Table 3 . Aspochalasin M (3), asperphenamate (4) and 4-OMe-asperphenamate (5) were inactive for all the tested microorganisms up to 64 g ml -1 .
Isolation of the secondary metabolites
Antimicrobial activity of the isolated compounds
Discussion
Fungi in the marine ecosystem comprise both obligatory fungi and facultative fungi 5 . According to Kohlmeyer and Kohlmeyer 19 , obligatory marine fungi grow and sporulate exclusively in a marine environment while facultative marine fungi have spread to the marine environment from terrestrial or freshwater habitats, but they also can exist well in the marine environment. The fungi isolated in the current study could be either obligatory or facultative 'marine fungi', hence other than using the term marine fungi, referring to them as marine/sponge-derived fungi is more appropriate as we have not determined the origin. A. flavipes has been reported from both terrestrial and marine sources [20] [21] [22] [23] . Therefore, whether A. flavipes isolated in this study is a facultative marine fungus, that has been accumulated through filter feeding or an obligatory marine fungus, which has originated in the internal tissues, is open to conjecture.
A. flavipes is known to produce a number of secondary metabolites 24 . However, the genomic sequence data of Aspergillus has revealed, there is potential for new natural products to be discovered from this source 25 . Therefore, studying the secondary metabolites production by A. flavipes from an untapped ecological setting may prove to be fruitful. In this study, five different culture media were utilized to facilitate the growth of fastidious fungal species who seek specific nutrients and conditions to emerge. The three fungal species isolated in this study emerged from either ME or MEA medium indicating that they prefer a medium rich with malt for their growth. Previous reports confirm the antibacterial activity of compounds 1 and 2 (refs 15, 26 26 . The results of the current study show that compounds 1 and 2, both of which have a hydroxyl at C-17, exhibit antibacterial activity in agreement with this argument. In another study, 1 and 2 are reported to inhibit the growth of four cancer cell lines and the authors imply that the ,-unsaturated ketone is an essential part of the pharmacophore 14 . Compound 3 which showed no antibacterial activity lacks both the ,-unsaturated ketone and the C-17 hydroxyl; instead, there is a hydroxyl at C-18 and a ketone at C-17. Based on the results obtained for the three aspochalasins 1-3 in the current study and the earlier arguments, we can suggest that the ,-unsaturated ketone and hydroxyl group at C-17 may well be essential for the antibacterial activity. Other than the above, 2 has shown 40% inhibition of glucose transport in A. sialophilus while 1 has shown no inhibition 27 . Although 3 was inactive against tested bacteria and fungi, it has shown modest activity against the cancer cell line HL-60 with an IC 50 value of 20 M (ref. 14).
In the current study, asperphenamate (4) and 4-OMeasperphenamate (5) were inactive against the microorganisms tested at up to 64 g ml -1 . In literature some studies have shown 4 and 5 to be antibacterial while some have reported contradictory results 18, 28 . In a study undertaken in China, 4 and 5 are reported to show selective activities against S. epidermidis, S. aureus, E. coli and B. cereus with MIC values of 10 M for S. epidermidis and >20 M for the other bacteria and inactive against B. subtilis, Micrococcus luteus and two marine pathogenic bacteria Vibrio parahaemolyticus and Listonella anguillarum 18 . The same study reports the absence of antifouling activity against the settlement of the larvae of the barnacle, Balanthus amphitrite 18 . In contrast, compound 4 isolated from Z. digitalis extracts showed no activity against the microorganisms E. coli, S. aureus and Cladosporium sphaerospermum 28 . Similarly, 4 derived synthetically failed to show any antibacterial activities against the tested microorganisms 28 . However, when 4 was isolated during a phytochemical study of Erythrina droogmansiana, radical scavenging potential with an IC 50 value of 3.31 mg ml -1 and moderate reducing power ability was observed 29 . In another study, 4 exhibited weak in vitro anti proliferative activities against T47D, MDA-MB231 and HL60 cell lines 30 .
Conclusion
By isolating the appealing compounds, aspochalasin B, D and M, asperphenamate and 4-OMe-asperphenamate from the fungus A. flavipes, the current research highlights the potential of isolating bioactive secondary metabolites from Sri Lankan sponge-derived fungi and that the marine habitat of Sri Lanka warrants further exploration for bioactive natural products.
